News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
701,566 Results
Type
Article (40342)
Company Profile (271)
Press Release (660953)
Multimedia
Podcasts (51)
Webinars (12)
Section
Business (205148)
Career Advice (2021)
Deals (35534)
Drug Delivery (97)
Drug Development (81358)
Employer Resources (172)
FDA (16217)
Job Trends (14919)
News (346642)
Policy (32663)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2586)
Accelerated approval (5)
Adcomms (20)
Allergies (82)
Alliances (49802)
ALS (87)
Alzheimer's disease (1379)
Antibody-drug conjugate (ADC) (126)
Approvals (16220)
Artificial intelligence (246)
Autoimmune disease (22)
Automation (16)
Bankruptcy (363)
Best Places to Work (11667)
BIOSECURE Act (20)
Biosimilars (106)
Biotechnology (190)
Bladder cancer (68)
Brain cancer (26)
Breast cancer (272)
Cancer (2174)
Cardiovascular disease (170)
Career advice (1688)
Career pathing (30)
CAR-T (147)
Cell therapy (411)
Cervical cancer (19)
Clinical research (66112)
Collaboration (822)
Compensation (519)
Complete response letters (19)
COVID-19 (2622)
CRISPR (38)
C-suite (233)
Cystic fibrosis (101)
Data (2095)
Decentralized trials (2)
Denatured (20)
Depression (42)
Diabetes (264)
Diagnostics (6379)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (121)
Drug pricing (100)
Drug shortages (25)
Duchenne muscular dystrophy (92)
Earnings (86574)
Editorial (35)
Employer branding (21)
Employer resources (146)
Events (112673)
Executive appointments (712)
FDA (17433)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (749)
Gene editing (102)
Generative AI (19)
Gene therapy (289)
GLP-1 (707)
Government (4428)
Grass and pollen (4)
Guidances (52)
Healthcare (18856)
Huntington's disease (24)
IgA nephropathy (24)
Immunology and inflammation (116)
Indications (28)
Infectious disease (2765)
Inflammatory bowel disease (138)
Inflation Reduction Act (10)
Influenza (51)
Intellectual property (93)
Interviews (312)
IPO (16536)
IRA (42)
Job creations (3665)
Job search strategy (1434)
Kidney cancer (10)
Labor market (38)
Layoffs (469)
Leadership (16)
Legal (7946)
Liver cancer (73)
Lung cancer (312)
Lymphoma (147)
Machine learning (6)
Management (58)
Manufacturing (296)
MASH (65)
Medical device (13380)
Medtech (13385)
Mergers & acquisitions (19525)
Metabolic disorders (671)
Multiple sclerosis (77)
NASH (16)
Neurodegenerative disease (85)
Neuropsychiatric disorders (27)
Neuroscience (1897)
NextGen: Class of 2025 (6554)
Non-profit (4495)
Northern California (2603)
Now hiring (39)
Obesity (358)
Opinion (209)
Ovarian cancer (73)
Pain (82)
Pancreatic cancer (82)
Parkinson's disease (146)
Partnered (21)
Patents (227)
Patient recruitment (105)
Peanut (46)
People (57605)
Pharmaceutical (67)
Pharmacy benefit managers (18)
Phase I (20616)
Phase II (29116)
Phase III (21677)
Pipeline (1140)
Policy (138)
Postmarket research (2569)
Preclinical (8747)
Press Release (65)
Prostate cancer (100)
Psychedelics (30)
Radiopharmaceuticals (245)
Rare diseases (374)
Real estate (5953)
Recruiting (65)
Regulatory (22318)
Reports (46)
Research institute (2340)
Resumes & cover letters (350)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (67)
Series A (131)
Series B (84)
Service/supplier (13)
Sickle cell disease (52)
Southern California (2242)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3631)
State (2)
Stomach cancer (13)
Supply chain (67)
Tariffs (33)
The Weekly (29)
United States (22526)
Vaccines (681)
Venture capitalists (43)
Weight loss (232)
Women's health (35)
Worklife (15)
Date
Today (52)
Last 7 days (644)
Last 30 days (2379)
Last 365 days (32866)
2025 (9885)
2024 (35347)
2023 (40204)
2022 (51322)
2021 (55876)
2020 (54214)
2019 (46702)
2018 (35157)
2017 (32254)
2016 (31678)
2015 (37742)
2014 (31506)
2013 (26538)
2012 (28808)
2011 (29457)
2010 (27547)
Location
Africa (722)
Alabama (52)
Alaska (7)
Arizona (230)
Arkansas (13)
Asia (38075)
Australia (6243)
California (5952)
Canada (1970)
China (505)
Colorado (262)
Connecticut (265)
Delaware (139)
Europe (81800)
Florida (878)
Georgia (202)
Idaho (58)
Illinois (522)
India (26)
Indiana (306)
Iowa (11)
Japan (157)
Kansas (103)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (872)
Massachusetts (4435)
Michigan (216)
Minnesota (384)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (60)
New Hampshire (63)
New Jersey (1682)
New Mexico (28)
New York (1690)
North Carolina (951)
North Dakota (7)
Northern California (2603)
Ohio (201)
Oklahoma (14)
Oregon (35)
Pennsylvania (1337)
Puerto Rico (11)
Rhode Island (32)
South America (1101)
South Carolina (22)
South Dakota (1)
Southern California (2242)
Tennessee (101)
Texas (884)
Utah (177)
Virginia (141)
Washington D.C. (62)
Washington State (547)
West Virginia (3)
Wisconsin (52)
701,566 Results for "replicate bioscience inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Replicate Bioscience to Participate in Upcoming Investor and Scientific Conferences
Replicate Bioscience will be participating in the following upcoming investor meetings.
March 1, 2024
·
2 min read
Press Releases
Replicate Bioscience Announces Publication of First-in-Human Data for Its Optimized srRNA Rabies Vaccine in Nature Communications
February 7, 2025
·
5 min read
Biotech Beach
Replicate Bioscience Announces Oral Presentations at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for use in infectious disease, oncology, autoimmune disease, and more, today announced acceptance of two oral presentations at the upcoming American Society of Gene & Cell Therapy (ASGCT) Annual Meeting, May 7-11 in Baltimore, Maryland.
April 22, 2024
·
2 min read
Drug Development
Replicate Bioscience Presents Positive Data from Phase 1 Trial and Preclinical Data with Novel Self-Replicating RNA at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Replicate Bioscience presented new preclinical data and will share interim clinical trial results from an ongoing Phase 1 study at the American Society of Gene & Cell Therapy Annual Meeting, May 7-11 in Baltimore, Maryland.
May 11, 2024
·
4 min read
Press Releases
Parse Biosciences Partners with Japanese Distributor, SCRUM Inc.
April 2, 2025
·
2 min read
Press Releases
Revelation Biosciences, Inc. Receives Continued NASDAQ Listing Approval
February 24, 2025
·
4 min read
Drug Development
Replicate Bioscience Announces Positive Initial Clinical Results for its Next Generation srRNA Technology
Replicate Bioscience today shared positive results from the Phase 1 trial of RBI-4000, its srRNA-based rabies vaccine.
February 14, 2024
·
4 min read
Press Releases
Ensysce Biosciences, Inc. Announces Exercise of Warrants for $2.2 Million Gross Proceeds
April 23, 2025
·
4 min read
Press Releases
Xenetic Biosciences, Inc. Releases Virtual Investor “What This Means” Segment
April 10, 2025
·
5 min read
Press Releases
Forte Biosciences, Inc. Announces Results and Provides Clinical Update
March 31, 2025
·
7 min read
1 of 70,157
Next
